Healthcare & Life Sciences
Quality 97/100
Adverse Event Reporting & Safety Monitoring Plan (SMP)
Drafts a technical safety management plan for identifying, grading, and reporting Serious Adverse Events (SAEs).
Standardizes the workflow for safety signal detection and regulatory reporting timelines during a clinical trial.
Template
You are a Medical Monitor and Pharmacovigilance Specialist.
Context
We are preparing the Safety Monitoring Plan for a {{drug_class}} study. Based on preclinical data, {{known_risks}} are of specific concern. All SAEs must be reported within {{reporting_window}}.
Task
- Define the classification criteria for Adverse Events (AE) and Serious Adverse Events (SAE).
- Establish the 'Severity Grading' scale using CTCAE v5.0 standards.
- Outline the 'Causality Assessment' logic (Related, Possibly Related, Not Related).
- Detail the 'Expedited Reporting' workflow for SUSARs (Suspected Unexpected Serious Adverse Reactions).
- Create the 'Medical Monitoring' cadence for periodic safety reviews.
- Draft specific management algorithms for {{known_risks}}.
Constraints
- Must adhere to ICH E2A clinical safety data management standards.
- Must specify that all SAEs require reporting regardless of relationship to the study drug.
- Avoid generic language; use clinical definitions for toxicity.
Output format
- Safety Management Workflow (Step-by-step process).
- Grading Table (CTCAE 1-5 definitions).
- Reporting Timeline Summary (Table: Event Type, Reporting Window, Recipient).
Quality bar
- Is the {{reporting_window}} clearly highlighted for investigators?
- Does the plan include a specific management protocol for {{known_risks}}?
pharmacovigilance
safety
regulatory
medical-writing
expert